The Collagen Factors of Rapid Progression of Keratoconus in Children.

NCT ID: NCT06722937

Last Updated: 2024-12-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-14

Study Completion Date

2025-04-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this observational study was to understand the differences in clinical features and mechanisms of keratoconus between children and adults. The main questions it aimed to answer as follows: (1) to understand the characteristics of keratoconus in Chinese children. (2) to observe corneal stromal cells at the cytological level using in vivo corneal laser confocal microscopy and explore the pathogenesis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Keratoconus is a progressive and asymmetric corneal dilation disease, in which the cornea presents as a conical protrusion, leading to irregular astigmatism, progressive myopia, corneal thinning, and subsequent visual impairment. If left untreated, acute corneal edema may occur in the late stage, resulting in a sharp decline in vision. This disease is a binocular disease and can occur unilaterally first. The incidence rate of the general population is 1/2000. Most of the diseases described in the literature began in adolescence, and about 90% of the patients were diagnosed at the age of 10. Some literature reported that the youngest patient was 4 years old, and the disease generally remained stable until about 40 years old.

Currently, research on pediatric keratoconus mainly includes the prevalence and morphological characteristics, as well as the progression of corneal collagen cross-linking surgery. The younger onset age of KC is often associated with rapid progression and late stage disease diagnosis. Scholars have observed that 88% of children develop KC after one year of diagnosis, and advocate for early corneal collagen cross-linking treatment for these children's eyes. However, the reasons for the onset and progression of keratoconus in children at a young age are not yet clear.

Due to the young age of onset and unclear reasons for the progression of pediatric keratoconus in clinical practice, as well as insufficient research on pediatric keratoconus in recent years, the clinical characteristics of pediatric keratoconus are still lacking, and the pathogenesis of pediatric keratoconus is still unclear. Therefore, this study aims to compare pediatric keratoconus with adult keratoconus, extract the characteristics of pediatric keratoconus, and use a live corneal laser confocal microscope to observe the stromal cellular structure inside pediatric keratoconus, in order to provide some clinical reference for the pathological understanding of pediatric keratoconus.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Keratoconus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

keratoconus pediatric Corneal biomechanics collagen

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Keratoconus group of children

Observation

Intervention Type OTHER

Observe the clinical natural changes of eye parameters of the subjects.

Keratoconus group of adult

Observation

Intervention Type OTHER

Observe the clinical natural changes of eye parameters of the subjects.

Control group of children

Observation

Intervention Type OTHER

Observe the clinical natural changes of eye parameters of the subjects.

Control group of adult

Observation

Intervention Type OTHER

Observe the clinical natural changes of eye parameters of the subjects.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation

Observe the clinical natural changes of eye parameters of the subjects.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ① Patients with keratoconus who visit the refractive clinic.

1. The height of the posterior corneal surface is greater than 16 microns under the Pentacam corneal topography.
2. ARTAve \< 424 microns, ARTMax \< 339 microns.
3. Clinical non-inflammatory or traumatic corneal thinning and corneal astigmatism.

* Aged between 10 and 50 years old, no gender restrictions.

* Agree to accept and complete follow-up examinations on time. ④ I and my guardian understand and agree to participate in this clinical trial and sign the informed consent form.

Exclusion Criteria

* ① There is a history of contact lens wearing in the last four weeks.

* poor fixation and can not cooperate with the examination. ③ History of eye trauma and surgery (including corneal collagen cross-linking surgery).

* History of other related eye diseases: corneal disease, glaucoma, retinal choroid disease, etc..

⑤ severe eye diseases affecting imaging such as dry eye, conjunctivitis and pterygium.

⑥ Any systemic disease affecting eye morphology and refractive interstitium.
Minimum Eligible Age

10 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongshan Ophthalmic Center,Sun Yat-Sen University

Guangzhou, Guangdong, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dan Li, MD

Role: CONTACT

Phone: +86 188 1149 6522

Email: [email protected]

Junwen Zeng, PhD

Role: CONTACT

Phone: +86 136 0286 0456

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yanjie Yan

Role: primary

Related Links

Access external resources that provide additional context or updates about the study.

https://www.chictr.org.cn/

Registration information of this study in China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023KYPJ328

Identifier Type: -

Identifier Source: org_study_id